Foamix Pharmaceuticals Ltd. Net Change in Cash
Foamix Pharmaceuticals Ltd. reported Net Change in Cash of $14.58 million for the 6-month period ending 2017-06-30, per its 6-K filed 2017-08-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-08-08
- 2017-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month $14.58M.
- 2016-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month $1.21M.
- 2015-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month -$8.06M.
- 2014-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month -$236.00K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 6 month |
|---|---|
| 2017-06-30 | $14.58M 6-K · filed 2017-08-08 |
| 2016-06-30 | $1.21M 6-K · filed 2017-08-08 |
| 2015-06-30 | -$8.06M 6-K · filed 2016-08-10 |
| 2014-06-30 | -$236.00K 6-K · filed 2015-10-19 |